Loading clinical trials...
Loading clinical trials...
Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months post injection.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Sollis Therapeutics, Inc.
NCT06216288 · Lumbosacral Radiculopathy, McKenzie Derangement Syndrome
NCT06558383 · Lumbosacral Radiculopathy
NCT06176196 · Painful Lumbosacral Radiculopathy
NCT07079202 · LUMBOSACRAL RADICULOPATHY, Chronic Low Back Pain
NCT03727100 · Lumbosacral Radiculopathy
Sollis Clinical Study Site 36
Mobile, Alabama
Sollis Clinical Study Site 44
Phoenix, Arizona
Sollis Clinical Study Site 40
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions